The purpose of this proposal is to determine how intestinal epithelial cells control the signaling functions of Toll-like Receptor 5 (TLR5), an important regulator of inflammatory bowel diseases (IBDs). Recent publications suggest that localization of adaptor proteins, necessary for innate immune receptor signaling, define the sub-cellular location from which TLRs signal. In accordance with this, preliminary data generated for this proposal suggests that the adaptor protein TIRAP, which has been shown to be required for TLR5 signaling, is found exclusively on the basolateral membrane of intestinal cells. Thus, we hypothesize that TIRAP's localization influences which surface (apical or basal) signaling occurs from on intestinal cells. Based on this hypothesis, this proposal seeks to (1) determine the localization of TLR5 and TIRAP in human intestinal epithelial cells (IECs), (2) Determine the functional role of TIRAP in determining the site of TLR5 signaling, and (3) Determine the mechanism by which TIRAP is localized within IECs. To address these aims in human IECs, genome editing strategies will be employed to make the genetic mutants needed for defining these innate immune signaling pathways. Microscopic techniques will be used to visualize interactions of adaptor proteins and receptors at sites of signaling, and cell biological assays wil determine the metabolic pathways important for directing where sites of signaling occur. This research has the potential to uncover new targets for those developing therapeutics for patients suffering from IBD.

Public Health Relevance

Improper activation of innate immune pathways in response to gut microbiota is thought to be a fundamental cause of IBDs, including Crohn's disease, in humans. Understanding how these innate immune pathways are triggered is paramount to development of therapies for patients with IBD. The research proposed here will address the underlying mechanisms that regulate how intestinal cells identify bacteria, and thus, has the power to influence future advancements in treatment and prevention of inflammation in IBD. Project Narrative The causes of intestinal inflammation that promote the development of digestive diseases, such as Crohn's disease, are not well understood. Thus, the purpose of this proposal is to determine how intestinal cells identify bacteria, and how this recognition event influences the inflammatory process. Understanding this biological process should yield valuable information for guiding development of treatments of inflammatory bowel diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK102317-02
Application #
8954970
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Densmore, Christine L
Project Start
2014-04-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
2
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
Rosadini, Charles V; Zanoni, Ivan; Odendall, Charlotte et al. (2015) A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4. Cell Host Microbe 18:682-93
Rosadini, Charles V; Kagan, Jonathan C (2015) Microbial strategies for antagonizing Toll-like-receptor signal transduction. Curr Opin Immunol 32:61-70